Detalhe da pesquisa
1.
6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial.
Lancet
; 393(10191): 2599-2612, 2019 06 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-31178152
2.
Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial.
Lancet
; 390(10099): 1048-1060, 2017 Sep 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28779963
3.
The development and audit of a nurse-led urology/oncology clinic.
Nurs Times
; 100(12): 54-6, 2004.
Artigo
em Inglês
| MEDLINE | ID: mdl-15067914
4.
Angiosarcoma of the scalp presenting in association with borderline malignant phyllodes tumour of the breast.
Sarcoma
; 7(3-4): 173-6, 2003.
Artigo
em Inglês
| MEDLINE | ID: mdl-18521383
5.
Cardiovascular mortality after radiotherapy for breast cancer. Article showed nothing new.
BMJ
; 326(7396): 983, 2003 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-12727749